Toxoplasmosis is a parasitic disease caused by the protozoan organism Toxoplasma gondii, which can infect virtually all warm-blooded animals including rabbits. While toxoplasmosis is one of the most common parasitic infections worldwide, clinical disease in domestic pet rabbits is considered rare. Rabbits serve as intermediate hosts for the parasite, meaning they can become infected and harbor tissue cysts but cannot complete the parasite's life cycle or shed infectious oocysts. Cats and other felids are the definitive hosts, being the only animals capable of producing and shedding the environmentally resistant oocysts that contaminate soil, water, and vegetation.
Infection in rabbits typically occurs through ingestion of sporulated oocysts present in food, water, or environments contaminated with cat feces. Fresh vegetables, hay, and grass collected from areas accessible to cats represent potential sources of infection. Congenital transmission from an infected mother rabbit to her offspring can also occur, potentially causing more severe disease in the developing young. Once ingested, the parasites initially multiply rapidly as tachyzoites before the immune response forces them to form dormant tissue cysts containing bradyzoites, which may persist in various organs throughout the rabbit's life.
The significance of toxoplasmosis in rabbits relates primarily to its potential for causing neurological disease and its zoonotic implications for humans handling or consuming rabbit meat. In most infected rabbits, the immune system successfully controls the infection, resulting in asymptomatic latent infection with tissue cysts that cause no clinical problems. However, in immunocompromised rabbits, young animals, or cases of heavy initial exposure, acute toxoplasmosis can develop with potentially severe consequences including encephalitis, pneumonia, and death. Neurological signs including head tilt, tremors, and seizures may occur when the brain is affected, requiring differentiation from other causes of neurological disease such as Encephalitozoon cuniculi infection.
Treatment of toxoplasmosis in rabbits is challenging and primarily effective during the acute tachyzoite phase of infection before tissue cysts form. Antiprotozoal medications including combinations of sulfonamides, pyrimethamine, and clindamycin have been used with variable success. Once tissue cysts have formed, they are largely resistant to available medications, though the latent infection typically causes no clinical problems in immunocompetent rabbits. Prevention focuses on minimizing exposure to environments contaminated with cat feces and sourcing food from protected areas. Importantly, while toxoplasmosis is zoonotic, live rabbits pose no direct infection risk to humans as they do not shed the parasite, though proper handling and cooking of rabbit meat intended for consumption remains important.
